Literature DB >> 20592108

Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam.

Quynh Mai Le1, Mutsumi Ito, Yukiko Muramoto, Phuong Vu Mai Hoang, Cuong Duc Vuong, Yuko Sakai-Tagawa, Maki Kiso, Makoto Ozawa, Ryo Takano, Yoshihiro Kawaoka.   

Abstract

Vietnam is one of the countries most affected by highly pathogenic H5N1 influenza A viruses. To evaluate the potential pathogenicity in mammals of H5N1 viruses isolated from humans in Vietnam, we determined the sequences of all eight genes of 22 human isolates collected between 2003 and 2008 and compared their virulence in mice. The isolates were classified into clade 1 and clade 2.3.4 and differed in pathogenicity for mice. Whilst lysine at position 627 of PB2 (PB2-627K) is a critical virulence determinant for clade 2.3.4 viruses, asparagine at position 701 of PB2 and other unknown virulence determinants appear to be involved in the high pathogenicity of clade 1 viruses, warranting further studies to determine the factors responsible for the high virulence of H5N1 viruses in mammals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592108      PMCID: PMC3052597          DOI: 10.1099/vir.0.021659-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


Since late 2003, highly pathogenic H5N1 avian influenza viruses have spread among poultry and wild birds in Asia, Africa and Europe (WHO, 2010b). These highly pathogenic H5N1 viruses have caused not only outbreaks in birds, but also several hundred human infections. As of 8 June 2010, >495 humans around the world have been infected and approximately 60 % of these infections have been fatal (WHO, 2010b). Upon acquisition of transmissibility among humans, H5N1 viruses will cause a severe pandemic. Vietnam is one of the countries most affected by highly pathogenic H5N1 viruses. Since 2003, H5N1 virus outbreaks in poultry have been reported in more than 45 of the 64 Vietnamese provinces (OIE, 2010). Nationwide vaccination programmes, which began in 2005, may have contributed, in part, to the reduction in outbreaks among poultry in 2006. However, H5N1 viruses re-emerged and outbreaks in poultry have again been reported since 2007. Since late 2003, when the first human infection was reported, Vietnam has seen many H5N1 virus patients; 119 cases have been reported to date. The fatality rate remains high: 45 % (93 patients with 42 fatal cases) for 2003–2005 and 65 % (26 patients with 17 fatal cases) for 2007–2010 (WHO, 2010b). H5N1 viruses isolated from patients vary in pathogenicity, as measured in a mouse model; some replicate systemically with lethal outcomes, whereas others do not (Gao ; Maines ). Using this animal model, determinants of virulence in mammals for H5N1 viruses have been identified. High haemagglutinin (HA) cleavability conferred by the presence of a series of basic amino acids at the cleavage site (Hatta ) is a critical determinant for virus systemic infection and high lethality not only in birds, but also in mice. The amino acid at position 627 of the PB2 protein (PB2-627), which is a host-range determinant (Subbarao ; Naffakh ), is a virulence determinant in mice (Hatta ). In addition, PB2-627K is important for virus replication in the upper respiratory tract of mice, suggesting that the amino acid residue at position 627 of the PB2 protein could facilitate person-to-person transmission of H5N1 viruses (Hatta ). Asparagine at position 701 of the PB2 protein (PB2-701N) is also a genetic marker of high virulence for H5N1 viruses in mammals, conferring efficient replication in mammalian cells (Gabriel ; Li ). In addition, four amino acid residues at the C terminus of the NS1 protein and serine at position 66 of the PB1-F2 protein (PB1-F2-66S) also contribute to high pathogenicity of H5N1 viruses in mice (Conenello ; Jackson ). In this study, to examine the pathogenicity in mammals of H5N1 viruses isolated from humans in northern Vietnam between 2003 and 2008, we infected mice with these H5N1 viruses and compared their virulence. We then analysed the genome sequences of these viruses to identify potential determinants of virulence in mammals. Madin–Darby canine kidney (MDCK) cells and an MDCK cell line overexpressing the human β-galactoside α-2,6-sialyltransferase I gene (MDCK-ST6GalI) (Hatakeyama ) were maintained in minimal essential medium (MEM) containing 5 % newborn calf serum at 37 °C in 5 % CO2. Nasal swabs, pharyngeal swabs and tracheal aspirates were collected from avian H5N1 influenza virus-infected patients in northern Vietnam and were sent to the NIHE in Vietnam (Dinh ). For H5N1 virus isolation, clinical specimens were inoculated onto MDCK cells in MEM containing 0.3 % BSA and incubated at 37 °C. MDCK-ST6GalI cells were used only for UT31203A virus, as it could not be isolated in MDCK cells. For UT31244II and UT31244III viruses, 10-day-old embryonated chicken eggs at 35 °C were used, as they were could not be isolated in MDCK or MDCK-ST6GalI cells. Stock viruses were propagated in MDCK cells at 37 °C, except for UT31244II and UT31244III, which were propagated in eggs at 35 °C and stored at −80 °C. Viral RNAs were extracted with ISOGEN (Nippon Gene) or a viral RNA mini kit (Qiagen) according to the manufacturers’ instructions. Extracted RNAs were reverse-transcribed with SuperScript III reverse transcriptase (Invitrogen) and an oligonucleotide complementary to the 12 nt sequence at the 3′ end of the viral RNA and amplified by PCR with Pfu-ultra (Stratagene) or Phusion (Finnzymes) high-fidelity DNA polymerase and primers specific for each segment of the H5N1 influenza viruses. Primer sequences are available upon request. The PCR products were cloned into the pCR-Blunt II-TOPO vector (Invitrogen). At least three clones for each sample were sequenced by using a BigDye Terminator version 3.1 Cycle Sequencing kit on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems). The GenBank accession numbers for the nucleotide sequences obtained in this study are HM114446–HM114621. Phylogenetic analysis of the sequence data was performed with clustal w software, which relies on neighbour-joining methods to generate phylogenetic trees. Estimates of the phylogenies were calculated by performing 100 neighbour-joining bootstrap replicates. To determine the 50 % mouse lethal dose (MLD50), groups (n=4 per group) of 6-week-old female BALB/c mice (Japan SLC) were anaesthetized with sevoflurane and infected intranasally with 50 μl of serial 10-fold dilutions of viruses, thereby creating doses ranging from 100 to 105 p.f.u. Mice were monitored daily for clinical signs of infection for 14 days post-infection. MLD50 values were calculated by using the method of Reed & Muench (1938). We sequenced the entire genomes of 22 H5N1 influenza viruses isolated from patients between December 2003 and February 2008 in northern Vietnam. The dates and locations of the virus isolations are summarized in Table 1 and Supplementary Fig. S1 (available in JGV Online). To understand the evolution of H5N1 influenza viruses in Vietnam, we performed phylogenetic analysis of the HA genes of these 22 strains in addition to other available sequences of H5N1 viruses isolated in Vietnam. According to the recent nomenclature system for highly pathogenic H5N1 viral HA genes, the viruses isolated from poultry in Vietnam were classified into seven different subclades: clades 0, 1, 2.3.2, 2.3.4, 3, 5 and 7, as reported previously (Wan et al., 2008; WHO, 2008, 2010a). The human H5N1 isolates studied here belonged to only two clades: the viruses isolated between 2003 and early 2005 were clade 1 and those isolated since late 2005 were clade 2.3.4 (Fig. 1).
Table 1.

Human H5N1 viruses analysed in this study

Virus strainAbbreviationDate of collectionProvince of collection*Clinical outcomeCollection site of specimenPassage history†
A/Vietnam/UT3028/2003‡UT3028Dec 2003Ha NamDiedTracheaC2
A/Vietnam/UT3028II/2003‡UT3028IIDec 2003Ha NamDiedTracheaC2
A/Vietnam/UT3030/2003UT3030Dec 2003Nam DinhDiedTracheaC2
A/Vietnam/UT3035/2003UT3035Dec 2003Bac GiangRecoveredNoseC2
A/Vietnam/UT3040/2004§UT3040Jan 2004Bac NinhDiedPharynxC2
A/Vietnam/UT3040II/2004§UT3040IIJan 2004Bac NinhDiedTracheaC2
A/Vietnam/UT3047III/2004UT3047IIIJan 2004Thai BinhDiedPharynxC2
A/Vietnam/UT3062/2004UT3062Jan 2004Bac GiangDiedPharynxC2
A/Vietnam/UT30259/2004UT30259Jul 2004Ha TayDiedTracheaC2
A/Vietnam/HN30262IIIM3/2004HN30262IIIM3Aug 2004Ha TayDiedTracheaC4
A/Vietnam/UT30408III/2005UT30408IIIFeb 2005Thai BinhRecoveredPharynxC2
A/Vietnam/UT30850/2005UT30850Oct 2005Ha NoiDiedTracheaC2
A/Vietnam/UT31203A/2007UT31203AMay 2007Vinh PhucRecoveredPharynxM1C1
A/Vietnam/UT31239/2007UT31239Jun 2007Thanh HoaRecoveredNoseC2
A/Vietnam/UT31244II/2007||UT31244IIJun 2007Ha NamDiedPharynxE2
A/Vietnam/UT31244III/2007||UT31244IIIJun 2007Ha NamDiedPharynxE2
A/Vietnam/UT31312II/2007UT31312IIJul 2007Ha TayDiedTracheaC2
A/Vietnam/HN31388M1/2007HN31388M1Dec 2007Son LaDiedTracheaC2
A/Vietnam/UT31394II/2008UT31394IIJan 2008Tuyen QuangDiedTracheaC2
A/Vietnam/UT31412II/2008UT31412IIFeb 2008Hai DuongDiedTracheaC2
A/Vietnam/UT31413II/2008UT31413IIFeb 2008Ninh BinhDiedTracheaC2
A/Vietnam/HN31432M/2008HN31432MFeb 2008Phu ThoDiedPharynxC2

*See location map (Supplementary Fig. S1).

†C, MDCK cells; M, MDCK-ST6GalI cells; E, eggs. The number indicates the number of passages.

‡A/Vietnam/UT3028/2003 and A/Vietnam/UT3028II/2003 were isolated from the same individual, but A/Vietnam/UT3028II/2003 was isolated 1 day later than A/Vietnam/UT3028/2003.

§A/Vietnam/UT3040/2004 and A/Vietnam/UT3040II/2004 were isolated from the same individual, but A/Vietnam/UT3040II/2004 was isolated 1 day later than A/Vietnam/UT3040/2004.

||A/Vietnam/UT31244II/2007 and A/Vietnam/UT31244III/2007 were isolated from the same individual, but A/Vietnam/UT31244III/2007 was isolated 10 days later than A/Vietnam/UT31244II/2007.

Fig. 1.

Phylogenetic relationships among the HA genes of H5N1 viruses isolated from patients in Vietnam. Numbers at branch nodes indicate neighbour-joining bootstrap values. Analysis was based on nt 77–1672 of the HA gene. The HA gene tree was rooted to A/goose/Guangdong/1/96. Viruses analysed in this study are shown in red. Bar, 0.01 nucleotide substitutions per site. Abbreviations: BHG, bar-headed goose; Ck, chicken; Dk, duck; Gs, goose; HC, house crow; MDk, Muscovy duck; Qa, quail; Tk, turkey; TS, tree sparrow; WSw, whooper swan.

Next, we investigated the phylogenetic relationships of the other viral genes. With the exception of the neuraminidase (NA) gene, the phylogenetic trees of seven gene segments showed similar evolutionary relationships to that of the HA gene (Supplementary Fig. S2, available in JGV Online). For the NA gene, although the phylogenetic relationship was similar to that of the HA gene, the clade 2.3.4 viruses were separated into two sublineages. These results indicate that the 22 human isolates analysed here belonged to two genetic groups: 11 viruses were in clade 1, whereas nine viruses were in clade 2.3.4, with UT30850 and HN31432M being slightly different from the others in their NA genes. To evaluate the pathogenicity of these human isolates in mammals, BALB/c mice were infected intranasally with these viruses and MLD50 values were determined. As shown in Table 2, the human isolates differed in virulence, ranging in their MLD50 from >105 p.f.u. for UT31413II to 0.46 p.f.u. for UT31239. Both virulent and avirulent viruses were found in clade 1 and clade 2.3.4, and did not correlate with clinical outcomes (Tables 1 and 2).
Table 2.

Virulence in BALB/c mice and molecular characterization of H5N1 viruses

Virus strainClade classificationAmino acidMLD50 [log10 (p.f.u.)]Virulence in mice*
PB2C terminus of NS1
627701
UT30281KDE-S-E-V2.3Low
UT3028II1KDE-S-E-V2.5Low
UT30301ENE-S-E-V2.5Low
UT30351EDE-S-E-V2.5Low
UT30401KD10 aa deletion0.3High
UT3040II1KD10 aa deletion3.3Low
UT3047III1ENE-S-E-V3.5Low
UT30621KDE-S-E-V0.4High
UT302591KDE-S-E-V1.3High
HN30262IIIM31ENE-S-E-I1.4High
UT30408III1KDE-S-E-V3.5Low
UT308502.3.4′†KDE-S-E-V1.0High
UT31203A2.3.4KDG-S-E-V0.2High
UT312392.3.4KDG-S-E-V−0.3 (0.46 p.f.u.)High
UT31244II‡2.3.4EDG-S-E-V4.7Low
UT31244III‡2.3.4EDG-S-E-V3.3Low
UT31312II2.3.4EDG-S-E-V4.0Low
HN31388M12.3.4E7/K1§DG-S-E-V2.5Low
UT31394II2.3.4KDG-S-E-V0.3High
UT31412II2.3.4KDG-S-E-V0.6High
UT31413II2.3.4EDG-S-E-V>5.0Low
HN31432M2.3.4′†ED10 aa deletion2.9Low

*Viruses with an MLD50 <102 p.f.u. were considered to be of high virulence in this study.

†Clade 2.3.4′ indicates that these isolates differ slightly from the others in the NA gene.

‡UT31244II and UT31244III lack 11 aa at the C terminus of the PB1-F2 protein.

§Number of clones possessing K or E of a total of eight clones.

We then correlated the results of the mouse pathogenicity data with the sequence information (Table 2). All isolates examined here contained polybasic amino acids at the cleavage site of the HA protein, which are necessary for the high virulence of H5N1 viruses in mice (Hatta ). No isolate possessed glutamic acid at position 92 of the NS1 protein (NS1-92E), which is associated with high virulence of these viruses in pigs (Seo ). Similarly, no isolates possessed PB1-F2-66S, which is another marker for high virulence of H5N1 viruses in mice. The PB1-F2 protein of isolates UT31244II and UT31244III possessed an 11 aa deletion at the C terminus. Although all of the isolates in clade 1 except for UT3035 possessed either PB2-627K or PB2-701N, which are responsible for high pathogenicity in mice, some viruses (UT3028, UT3028II, UT3030, UT3040II, UT3047III and UT30408III) showed relatively low virulence for mice. UT3035, which has neither PB2-627K nor PB2-701N, had low virulence. These results indicate that although PB2-627K and PB2-701N contribute to high pathogenicity in mice, they are not sufficient to confer high virulence in mice. On the other hand, all of the clade 2.3.4 isolates that possessed PB2-627K showed high virulence in mice, whereas those that possessed PB2-627E (avian type) were of low virulence. Four amino acid residues (E-S-E-V) at the C terminus of NS1 are associated with virulence of H5N1 viruses in mice (Jackson ). Among the clade 1 viruses tested, some (UT3028, UT3028II, UT3030, UT3035, UT3047III and UT30408III) were avirulent even though they possessed this motif. Whilst most of the clade 2.3.4 viruses in this study lacked this sequence motif, some were virulent, indicating that, like PB2-627K and PB2-701N, there may be some other sequence motif that can substitute for this NS1 sequence motif. These results suggest that, in addition to the HA cleavage-site sequence, PB2-627K, PB2-701N, the C terminus of NS1 and PB1-F2-66S, there are other virulence determinants that have yet to be discovered. In this study, we phylogenetically investigated 22 H5N1 viruses isolated from humans in northern Vietnam and determined their pathogenicity in mice. All of the Vietnamese human isolates examined in this study belonged to either clade 1 or clade 2.3.4. Both of these lineages contain human H5N1 viruses isolated in other Asian countries besides Vietnam. Although none of these human isolates from northern Vietnam belonged to clades 2.3.2, 3, 5 or 7, a limited number of human isolates from China in 2009 were assigned to clades 2.3.2 and 7 (WHO, 2010a). We also found differences in pathogenicity for mice between two strains that were isolated from the same individual but on different days and are genetically very closely related to each other: UT3040 showed high virulence, whereas UT3040II was of low virulence, even though both strains possessed the human-type PB2-627K. These two strains differ in their amino acid sequences by only three residues (one each in PB1, PA and NP; Supplementary Table S1, available in JGV Online). The amino acid residues found in PB1 and NP of UT3040II are specific for this virus among the 22 human isolates analysed here, implying that these amino acids may contribute to its attenuated phenotype in mice. Because glutamic acid at position 142 of the PA of UT3040 was also found in UT3028II and HN31432M, which were of low virulence, it remains unclear whether this amino acid residue in PA contributes to pathogenicity. To determine whether these mutations in the polymerase complex affect polymerase activity, the polymerase activity of UT3040 and UT3040II was assessed by use of a plasmid-based minigenome assay essentially as described by Ozawa (Supplementary Fig. S3, available in JGV Online). Briefly, human embryonic kidney 293 cells were co-transfected with plasmids for the expression of the viral polymerase complex proteins (i.e. PB2, PB1, PA and NP) and a firefly luciferase-encoding influenza viral minigenome together with pGL4.74[hRluc/TK] (Promega), which expresses Renilla luciferase and served as an internal control. Firefly luciferase activity was measured by using a dual-luciferase reporter assay system (Promega) according to the manufacturer's instructions. The viral polymerase complex from UT3040 exhibited significantly higher activity than that from UT3040II, suggesting that the difference in virulence between UT3040 and UT3040II originates from the difference in their polymerase activities. Reverse-genetics studies will help to determine the amino acid residues responsible for the difference in virulence between these viruses.
  17 in total

1.  Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-03-12

2.  Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.

Authors:  Shuji Hatakeyama; Yuko Sakai-Tagawa; Maki Kiso; Hideo Goto; Chiharu Kawakami; Keiko Mitamura; Norio Sugaya; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals.

Authors:  Taronna R Maines; Xui Hua Lu; Steven M Erb; Lindsay Edwards; Jeannette Guarner; Patricia W Greer; Doan C Nguyen; Kristy J Szretter; Li-Mei Chen; Pranee Thawatsupha; Malinee Chittaganpitch; Sunthareeya Waicharoen; Diep T Nguyen; Tung Nguyen; Hanh H T Nguyen; Jae-Hong Kim; Long T Hoang; Chun Kang; Lien S Phuong; Wilina Lim; Sherif Zaki; Ruben O Donis; Nancy J Cox; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model.

Authors:  Zejun Li; Hualan Chen; Peirong Jiao; Guohua Deng; Guobin Tian; Yanbing Li; Erich Hoffmann; Robert G Webster; Yumiko Matsuoka; Kangzhen Yu
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.

Authors:  M Hatta; P Gao; P Halfmann; Y Kawaoka
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

6.  Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong.

Authors:  P Gao; S Watanabe; T Ito; H Goto; K Wells; M McGregor; A J Cooley; Y Kawaoka
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses.

Authors:  N Naffakh; P Massin; N Escriou; B Crescenzo-Chaigne; S van der Werf
Journal:  J Gen Virol       Date:  2000-05       Impact factor: 3.891

8.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range.

Authors:  E K Subbarao; W London; B R Murphy
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

10.  A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence.

Authors:  Gina M Conenello; Dmitriy Zamarin; Lucy A Perrone; Terrence Tumpey; Peter Palese
Journal:  PLoS Pathog       Date:  2007-10-05       Impact factor: 6.823

View more
  23 in total

1.  Seroprevalence survey of avian influenza A(H5N1) among live poultry market workers in northern Viet Nam, 2011.

Authors:  Tham Chi Dung; Pham Ngoc Dinh; Vu Sinh Nam; Luong Minh Tan; Nguyen Le Khanh Hang; Le Thi Thanh; Le Quynh Mai
Journal:  Western Pac Surveill Response J       Date:  2014-11-18

2.  Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.

Authors:  Mitsutaka Kitano; Yasushi Itoh; Hirohito Ishigaki; Misako Nakayama; Hideaki Ishida; Van Loi Pham; Masahiko Arikata; Shintaro Shichinohe; Hideaki Tsuchiya; Naoko Kitagawa; Masanori Kobayashi; Ryu Yoshida; Akihiko Sato; Quynh Mai Le; Yoshihiro Kawaoka; Kazumasa Ogasawara
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

3.  Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.

Authors:  Ryo Takano; Maki Kiso; Manabu Igarashi; Quynh Mai Le; Masakazu Sekijima; Kimihito Ito; Ayato Takada; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2012-10-10       Impact factor: 5.226

4.  Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses.

Authors:  Saori Sakabe; Kiyoko Iwatsuki-Horimoto; Ryo Takano; Chairul A Nidom; Mai Thi Quynh Le; Tokiko Nagamura-Inoue; Taisuke Horimoto; Naohide Yamashita; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2011-03-02       Impact factor: 3.891

5.  PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice.

Authors:  Bin Zhou; Yan Li; Rebecca Halpin; Erin Hine; David J Spiro; David E Wentworth
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

6.  Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells.

Authors:  Benjamin Mänz; Linda Brunotte; Peter Reuther; Martin Schwemmle
Journal:  Nat Commun       Date:  2012-05-01       Impact factor: 14.919

7.  Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission.

Authors:  Qinfang Liu; Bin Zhou; Wenjun Ma; Bhupinder Bawa; Jingjiao Ma; Wei Wang; Yuekun Lang; Young Lyoo; Rebecca A Halpin; Xudong Lin; Timothy B Stockwell; Richard Webby; David E Wentworth; Juergen A Richt
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

8.  Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.

Authors:  Yukiko Muramoto; Jason E Shoemaker; Mai Quynh Le; Yasushi Itoh; Daisuke Tamura; Yuko Sakai-Tagawa; Hirotaka Imai; Ryuta Uraki; Ryo Takano; Eiryo Kawakami; Mutsumi Ito; Kiyoko Okamoto; Hirohito Ishigaki; Hitomi Mimuro; Chihiro Sasakawa; Yukiko Matsuoka; Takeshi Noda; Satoshi Fukuyama; Kazumasa Ogasawara; Hiroaki Kitano; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

9.  Novel residues in avian influenza virus PB2 protein affect virulence in mammalian hosts.

Authors:  Shufang Fan; Masato Hatta; Jin Hyun Kim; Peter Halfmann; Masaki Imai; Catherine A Macken; Mai Quynh Le; Tung Nguyen; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nat Commun       Date:  2014-10-07       Impact factor: 14.919

10.  A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets.

Authors:  Masaki Imai; Tokiko Watanabe; Maki Kiso; Noriko Nakajima; Seiya Yamayoshi; Kiyoko Iwatsuki-Horimoto; Masato Hatta; Shinya Yamada; Mutsumi Ito; Yuko Sakai-Tagawa; Masayuki Shirakura; Emi Takashita; Seiichiro Fujisaki; Ryan McBride; Andrew J Thompson; Kenta Takahashi; Tadashi Maemura; Hiromichi Mitake; Shiho Chiba; Gongxun Zhong; Shufang Fan; Kohei Oishi; Atsuhiro Yasuhara; Kosuke Takada; Tomomi Nakao; Satoshi Fukuyama; Makoto Yamashita; Tiago J S Lopes; Gabriele Neumann; Takato Odagiri; Shinji Watanabe; Yuelong Shu; James C Paulson; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  Cell Host Microbe       Date:  2017-10-19       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.